Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Leiner revising cold, menstrual pain, motion sickness claims in response to FDA concerns.

This article was originally published in The Tan Sheet

Executive Summary

LEINER REVISING COLD, MENSTRUAL PAIN, MOTION SICKNESS CLAIMS for three dietary supplement products after receiving recent notification from FDA that the statements, which already had been modified once, still constitute drug claims. Leiner plans to change the claims to more closely adhere to the Dietary Supplement Health & Education Act; the amended labeling will appear on the products Your Life Echinacea and Goldenseal, Your Life Dong Quai and Your Life Ginger in 1997.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS086836

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel